About: Treatment of rheumatoid arthritis: we are getting there

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of rheumatoid arthritis: we are getting there Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 26 June 2009

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2009 (fr) наукова стаття, опублікована в червні 2009 (uk) scientific article published on 26 June 2009 (en) artículu científicu espublizáu en xunu de 2009 (ast)
publication date	wds:Q84135709-2B3BDBE1-A462-4420-9151-71277B825422
publication date	2009-06-26 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q84135709-06323B2A-1D58-4CF5-AAE0-6F97565931F6
language of work or name	English
cites work	wds:Q84135709-0619F05D-A625-4D9D-87E8-AFCFA5EAE3A9 wds:Q84135709-3FE06D7E-27F6-4633-884E-E1E4F38494F5 wds:Q84135709-5D885754-BC17-499A-AD31-29FB2DDF2F4E wds:Q84135709-75860B3D-41B9-407D-B842-2625B0774067 wds:Q84135709-8300F49E-234C-4DC5-BEB6-58A2EDE73D3B wds:Q84135709-862C6187-E5A3-49C4-B31A-64836B8EEF04 wds:Q84135709-8B64EE90-C3BA-4002-AEEB-1485D56E97C9 wds:Q84135709-A77920CC-8751-41F5-B8E0-874215668B49 wds:Q84135709-CE96CE32-64CC-40C5-BDEC-FEFC17C526BB wds:Q84135709-DF221354-16A3-4F04-BFDE-59613FA087FB wds:Q84135709-F35A0C9C-DC43-4836-9D61-5072AC1BF70F
cites work	Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor? Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug. Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities. Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors
author name string	wds:Q84135709-00204EF2-4124-4430-B412-6D702DBF8ADC
author name string	Yusuf Yazici
rdfs:label	Treatment of rheumatoid arthritis: we are getting there (en) Treatment of rheumatoid arthritis: we are getting there (nl)
skos:prefLabel	Treatment of rheumatoid arthritis: we are getting there (en) Treatment of rheumatoid arthritis: we are getting there (nl)
name	Treatment of rheumatoid arthritis: we are getting there (en) Treatment of rheumatoid arthritis: we are getting there (nl)
title	wds:Q84135709-1F536F3A-3A36-4A5C-940A-AAC6398EA1AA
title	Treatment of rheumatoid arthritis: we are getting there (en)
page(s)	wds:Q84135709-FD76807C-FDC2-47D4-99C8-ED5C6BE218FB
page(s)	178-180
instance of	wds:Q84135709-BE0D35B8-95BE-48C2-AE91-2F339493E766
instance of	scholarly article
main subject	wds:Q84135709-44FF8429-E21D-4F9A-965E-2697B08BA945
main subject	rheumatoid arthritis
PubMed ID	wds:Q84135709-587016FD-57AB-46EB-8CD0-B3541D8C7288
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19560809
PubMed ID	19560809
published in	wds:Q84135709-28194EC5-B7BA-4813-9A19-D2F5B15C4035
published in	The Lancet
issue	wds:Q84135709-0E4AA5E2-32EC-4F25-A5E1-FBDB95F1D1E2
volume	wds:Q84135709-ED90786D-1963-4CB4-B7C5-8DD0EE2131AE
issue	9685
volume	374
DOI	wds:Q84135709-EE83D1FE-DFF1-4544-A323-157B3577963A
DOI	http://dx.doi.org/10.1016/S0140-6736(09)60792-3
DOI	10.1016/S0140-6736(09)60792-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q84135709
is cites work of	A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort Golimumab for rheumatoid arthritis Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys Rheumatoid arthritis: When should we use rituximab to treat RA? Janus kinase inhibitors Therapy: what should we do after the failure of a first anti-TNF? CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response Abatacept versus other biologics in methotrexate inadequate responders with rheumatoid arthritis: you like tomato and I like tomahto... let's call the whole thing off. Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions Rheumatoid arthritis: Evidence-based rather than habit-based treatment options Costimulation pathway blockade in kidney transplant recipients with de-novo rheumatoid arthritis
is cites work of	wds:Q35054330-4DED6226-038B-4B00-9A71-8C5F960BF274 wds:Q84237809-31C6E215-31E5-4162-9E1B-B1FE75DE2BF3 wds:Q35583230-3865018C-EAEB-4B33-91CC-0A5D9A260BB7 wds:Q43963029-E6F7D230-7D76-4D44-A3E6-CF98BB3690F2 wds:Q84801793-7D4BA087-58CB-4BD7-AB5A-9F53C030300E wds:Q24240895-0CAC621D-2DA4-4D05-A2BF-60BC9B5DA301 wds:Q58802123-F85268CB-BEE5-4583-B2A6-090D58523BF4 wds:Q92714001-86349916-1807-401B-A2E4-F5B8B3C361E4 wds:Q84235020-5FF85EFD-32FA-4E25-8D8C-DA4609292244 wds:Q43218551-B19B0E27-6D5D-44F3-8D70-71363A8DCB34 wds:Q58564655-3BE6F9DD-B088-4560-AE66-BB01D4727A82 wds:Q87130237-9B97D7D3-0612-4622-8B7D-BBDF9D8D6441 wds:Q89667845-46BF409A-7590-429D-A86F-4F8CA177479E wds:Q36084902-11BA70C4-E980-4BBA-BC4A-69A45BCBB2C0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software